06.05.2019 08:00:02

DGAP-News: CompuGroup Medical SE Reports Results for First Quarter of 2019

DGAP-News: CompuGroup Medical SE / Key word(s): Quarter Results
CompuGroup Medical SE Reports Results for First Quarter of 2019

06.05.2019 / 08:00
The issuer is solely responsible for the content of this announcement.


CompuGroup Medical SE Reports Results for First Quarter of 2019

Koblenz, May 06, 2019 - CompuGroup Medical SE (CGM) today reported its financial results for the first quarter of 2019. The Koblenz-based company, one of the world's leading providers of eHealth solutions, generated a revenue of EUR 175 million compared to EUR 166 million in the same period of the previous year. Also favored by regulatory accounting changes, consolidated earnings before interest, taxes, depreciation, and amortization (EBITDA) and operating margin both rose to EUR 50 million and 28 percent in the first quarter of 2019, compared with EUR 39 million and 23 percent in the same period of the previous year.

CGM is thus making a strong start to the year once again. Business with software solutions for private practice physicians and dentists started in the first quarter of 2019 with a growth of 4 percent, despite increasing market saturation in the roll-out of the Telematics Infrastructure (TI). Practices participating in the National Association of Statutory Health Insurance Physician's Care in Germany who have not ordered their connection to the TI by March 31, must now accept sanctions until they have realized their connection to the TI. Orders for connection components that continue to be subsidized in order to avoid longer-lasting income disadvantages are nevertheless still possible. By this date, 52,500 orders had been received for the CGM connectivity package, of which 46,000 had already been delivered.

The Pharmacy (Pharmacy Information Systems, PCS), Hospital (Hospital Information Systems, HIS) and Health Connectivity Services (HCS) segments grew more strongly than expected in the first quarter: In the PCS segment, CGM achieved an organic growth of 5 percent with established products and services as well as new opportunities through the implementation of the EU directive securPharm. The HIS segment with an organic growth of 10 percent is driven by the strong overall performance in the German-speaking DACH region (Germany, Austria, Switzerland) and a recovery of the hospital market in Poland.

"The overall strong performance in the first quarter gives us a positive outlook for the current year. I am particularly pleased with the good increase in recurring revenues from the business with doctors and dentists of almost 19 % compared with the same period of the previous year.," emphasizes Frank Gotthardt, CEO of CompuGroup Medical SE. "The growth in all of our segments shows that modern eHealth applications are becoming increasingly important across all sectors of the healthcare system. Our company is the driving force for intelligent networking among health professionals, involving all citizens. For no one should suffer or even die just because medical information is missing somewhere at some point."

CompuGroup Medical confirms the forecast for the fiscal year of 2019, which had been published with the 2018 Annual Report. Accordingly, the company expects consolidated revenues of between EUR 720 million and EUR 750 million for the current year and consolidated operating earnings (EBITDA) of between EUR 190 million and EUR 205 million.

Conference call for journalists, investors and analysts:
The Management Board of CompuGroup Medical SE will present the results today at 3 p.m. (CET) in an analyst and investor conference.

To participate in the conference call, please dial one of the following telephone numbers and enter the confirmation code:

+49 69 2017 4422 0 (Germany)
+44 20 300 924 70 (UK)
+1 877 423 083 0 (USA)
Confirmation code: 76003106#

A presentation will be available for download on cgm.com/IR_Presentation prior to the conference call and can also be viewed live at: https://webcasts.eqs.com/compugroup20190506/no-audio

About CompuGroup Medical SE
CompuGroup Medical is one of the leading eHealth companies in the world. With a revenue base of approximately EUR 717 million in 2018, its software products are designed to support all medical and organizational activities in doctors' offices, pharmacies, laboratories and hospitals. Its information services for all parties involved in the healthcare system and its web-based personal health records contribute towards safer and more efficient healthcare. CompuGroup Medical's services are based on a unique customer base of more than 1 million users, including doctors, dentists, pharmacists and other service providers in inpatient and outpatient facilities. With locations in 19 countries and products in 56 countries worldwide, CompuGroup Medical is the eHealth company with one of the highest coverage among eHealth service providers. Approximately 5,000 highly qualified employees support customers with innovative solutions for the steadily growing demands of the healthcare system.

Contact for media representatives:

CompuGroup Medical SE
Michael Franz

Head of Brand Communication
P +49 (0) 261 8000-6100
F +49 (0) 261 8000-3100
e-Mail: press@cgm.com

06.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de

Language: English
Company: CompuGroup Medical SE
Maria Trost 21
56070 Koblenz
Phone: +49 (0)261 8000 6200
Fax: +49 (0)261 8000 3200
E-mail: investor@cgm.com
Internet: www.cgm.com
ISIN: DE0005437305
WKN: 543730
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 807257

End of News DGAP News Service

807257  06.05.2019